Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of radotinib in Parkinson's disease; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Radotinib (radotinib)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING